ObsEva (NASDAQ:OBSV) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the stock.

ObsEva Stock Performance

The business has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.04. The stock has a market cap of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.